OpSens Announces First Quarter fiscal 2021 financial Results
13 January 2021OpSens Announces First Quarter fiscal 2021 financial Results Quebec City, Quebec, January 13, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the first quarter of fiscal 2021, ended November 30, 2020….
OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021
6 January 2021OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, January 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its…
OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
24 November 2020OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Quebec City, Quebec, November 24, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, is presenting at the Piper Sandler 32nd Annual Virtual Healthcare Conference, and…
OpSens announces fourth quarter and fiscal year 2020 results
19 November 2020OpSens Announces Fourth Quarter And Fiscal Year 2020 Financial Results Quebec City, Quebec, November 19, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the fourth quarter and fiscal year 2020 ended August 31, 2020. Financial Highlights Sales of product at $29.5 million in FY 2020 compared to prior…
OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™
18 November 2020OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™ Quebec City, Quebec, November 18, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has been recognized in Deloitte’s…
OpSens to Present at the Virtual Fall Investor Summit On November 16
13 November 2020Access OpSens’ presentation
OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020
12 November 2020OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020 Conference call to be conducted on November 19, 2020 at 11:00 am ET Quebec City, Quebec, November 12, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second generation fiber optic pressure guidewire to diagnose…
OpSens to Present at the Virtual Fall Investor Summit On November 16
10 November 2020OpSens to Present at the Virtual Fall Investor Summit On November 16 Quebec City, Quebec, November 10, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, will present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at…
OpSens Awarded Contract by Major U.S. Group Purchasing Organization
14 October 2020OPSENS AWARDED CONTRACT BY MAJOR U.S. GROUP PURCHASING ORGANIZATION OptoWire gains access to more than 50 PCI centers Quebec City, Quebec, October 14, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, announced today it has been…
OpSens Announces Q3 Results 2020
15 July 2020Quebec City, Quebec, July 15, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2020. Highlights Net earnings of $0.1 M for the third quarter ended May 31, 2020 compared with a net loss of $1.1 M for the corresponding period in 2019; Consolidated revenues of…